Cellectar Biosciences Inc (CLRB) progresses with regulatory approvals and partnerships, while navigating financial hurdles for future growth.

Q3 2025 Management View CEO James Caruso announced significant progress in the third quarter, emphasizing "strong operational execution on key corporate priorities, including the strengthening of our ...